Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1750432rdf:typepubmed:Citationlld:pubmed
pubmed-article:1750432lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:1750432lifeskim:mentionsumls-concept:C0012634lld:lifeskim
pubmed-article:1750432lifeskim:mentionsumls-concept:C0332307lld:lifeskim
pubmed-article:1750432lifeskim:mentionsumls-concept:C0008350lld:lifeskim
pubmed-article:1750432lifeskim:mentionsumls-concept:C0443146lld:lifeskim
pubmed-article:1750432lifeskim:mentionsumls-concept:C2745955lld:lifeskim
pubmed-article:1750432lifeskim:mentionsumls-concept:C0332183lld:lifeskim
pubmed-article:1750432pubmed:issue6lld:pubmed
pubmed-article:1750432pubmed:dateCreated1992-1-23lld:pubmed
pubmed-article:1750432pubmed:abstractTextThis study assesses the occurrence of asplenism and gallstones in patients with autoimmune polyglandular disease type I (APG I).lld:pubmed
pubmed-article:1750432pubmed:languageenglld:pubmed
pubmed-article:1750432pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1750432pubmed:citationSubsetAIMlld:pubmed
pubmed-article:1750432pubmed:statusMEDLINElld:pubmed
pubmed-article:1750432pubmed:monthDeclld:pubmed
pubmed-article:1750432pubmed:issn0002-9343lld:pubmed
pubmed-article:1750432pubmed:authorpubmed-author:FleisherT ATAlld:pubmed
pubmed-article:1750432pubmed:authorpubmed-author:ChrousosG PGPlld:pubmed
pubmed-article:1750432pubmed:authorpubmed-author:FeuillanPPlld:pubmed
pubmed-article:1750432pubmed:authorpubmed-author:ThomasP MPMlld:pubmed
pubmed-article:1750432pubmed:authorpubmed-author:FriedmanT CTClld:pubmed
pubmed-article:1750432pubmed:authorpubmed-author:CassorlaFFlld:pubmed
pubmed-article:1750432pubmed:authorpubmed-author:ParkesR BRBlld:pubmed
pubmed-article:1750432pubmed:issnTypePrintlld:pubmed
pubmed-article:1750432pubmed:volume91lld:pubmed
pubmed-article:1750432pubmed:ownerNLMlld:pubmed
pubmed-article:1750432pubmed:authorsCompleteYlld:pubmed
pubmed-article:1750432pubmed:pagination625-30lld:pubmed
pubmed-article:1750432pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:1750432pubmed:meshHeadingpubmed-meshheading:1750432-...lld:pubmed
pubmed-article:1750432pubmed:meshHeadingpubmed-meshheading:1750432-...lld:pubmed
pubmed-article:1750432pubmed:meshHeadingpubmed-meshheading:1750432-...lld:pubmed
pubmed-article:1750432pubmed:meshHeadingpubmed-meshheading:1750432-...lld:pubmed
pubmed-article:1750432pubmed:meshHeadingpubmed-meshheading:1750432-...lld:pubmed
pubmed-article:1750432pubmed:meshHeadingpubmed-meshheading:1750432-...lld:pubmed
pubmed-article:1750432pubmed:meshHeadingpubmed-meshheading:1750432-...lld:pubmed
pubmed-article:1750432pubmed:meshHeadingpubmed-meshheading:1750432-...lld:pubmed
pubmed-article:1750432pubmed:meshHeadingpubmed-meshheading:1750432-...lld:pubmed
pubmed-article:1750432pubmed:meshHeadingpubmed-meshheading:1750432-...lld:pubmed
pubmed-article:1750432pubmed:meshHeadingpubmed-meshheading:1750432-...lld:pubmed
pubmed-article:1750432pubmed:year1991lld:pubmed
pubmed-article:1750432pubmed:articleTitleFrequent occurrence of asplenism and cholelithiasis in patients with autoimmune polyglandular disease type I.lld:pubmed
pubmed-article:1750432pubmed:affiliationDevelopmental Endocrinology Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892.lld:pubmed
pubmed-article:1750432pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1750432lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1750432lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1750432lld:pubmed